Alan J. Wein

发表

Effects of Bowman–Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia * †

A. Wein, K. Propert, W. Mckenna, 2001, The Prostate.

Phase II trial of tamoxifen in metastatic carcinoma of the prostate

J. Glick, H. Brodovsky, K. Padavic, 1982, Cancer.

Prostate specific antigen outcome based on the extent of extracapsular extension and margin status in patients with seminal vesicle negative prostate carcinoma of Gleason score ≤ 7

A. D'Amico, D. Schultz, A. Wein, 2000, Cancer.

Prostatic cancer after prostatectomy for benign disease

J. Glick, T. Malloy, Ira S. Schwartz, 1986, Cancer.

Calculated prostate carcinoma volume

A. D'Amico, D. Schultz, S. Malkowicz, 1998, Cancer.

The burden of out‐of‐pocket and indirect costs of prostate cancer

A. Wein, J. Gallo, S. Chhatre, 2010, The Prostate.

A comparison of preoperative radiotherapy regimens for bladder carcinoma. The university of Pennsylvania experience

L. Solin, A. Wein, R. Whittington, 1988, Cancer.

Ethnic variation in return to baseline values of patient‐reported outcomes in older prostate cancer patients

S. Chhatre, R. Jayadevappa, S. Malkowicz, 2007, Cancer.

Trajectory of Depression among Prostate Cancer Patients: A Secondary Analysis of a Randomized Controlled Trial

N. Vapiwala, S. Chhatre, D. Newman, 2023, Cancers.

Defining pathological variables to predict biochemical failure in patients with positive surgical margins at radical prostatectomy: implications for adjuvant radiotherapy

S. Sonnad, S. Malkowicz, J. Tomaszewski, 2009, BJU international.

Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy

A. Renshaw, A. D'Amico, J. Richie, 1998, Cancer.

Racial differences in well-being and cancer concerns in prostate cancer patients

S. Chhatre, R. Jayadevappa, S. Malkowicz, 2011, Journal of cancer survivorship : research and practice.

Predictors of patient reported outcomes and cost of care in younger men with newly diagnosed prostate cancer

S. Chhatre, R. Jayadevappa, S. Malkowicz, 2009, The Prostate.

Joint effects of inflammation and androgen metabolism on prostate cancer severity

T. Rebbeck, A. Wein, S. Malkowicz, 2008, International journal of cancer.

Satisfaction with Care: A Measure of Quality of Care in Prostate Cancer Patients

A. Wein, S. Chhatre, R. Jayadevappa, 2010, Medical decision making : an international journal of the Society for Medical Decision Making.

Biochemical Outcome After Radical Prostatectomy , External Beam Radiation Therapy , or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer

S B Malkowicz, A. Renshaw, A. D'Amico, 2000 .

Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era.

S B Malkowicz, A. D'Amico, J. Richie, 2001, The Journal of urology.

The presence of high-grade prostatic intraepithelial neoplasia or atypia on prostate biopsy does not adversely affect prostatectomy outcomes for patients otherwise eligible for active surveillance.

S. Malkowicz, E. Pietzak, K. V. Van Arsdalen, 2014, Urology.

A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer.

A. D'Amico, D. Schultz, M. Schnall, 1995, The Journal of urology.

Estimating the impact on prostate cancer mortality of incorporating prostate-specific antigen testing into screening.

A. Renshaw, A. D'Amico, J. Richie, 2001, Urology.

Outcome based staging for clinically localized adenocarcinoma of the prostate.

A. D'Amico, D. Schultz, A. Wein, 1997, The Journal of urology.

Combination of the preoperative PSA level, biopsy gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer.

A. D'Amico, Ming-Hui Chen, A. Wein, 2000, Urology.

The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer.

A. D'Amico, Ming-Hui Chen, A. Wein, 1998, The Journal of urology.

Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer.

A. Renshaw, A. D'Amico, Ming-Hui Chen, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The impact of the inclusion of endorectal coil magnetic resonance imaging in a multivariate analysis to predict clinically unsuspected extraprostatic cancer

A. D'Amico, D. Schultz, M. Schnall, 1995, Cancer.

Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml.

A. D'Amico, I. Kaplan, C. Coleman, 1997, International journal of radiation oncology, biology, physics.

Effects of Bowman–Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia * †

K. Propert, D. Vaughn, S. Malkowicz, 2001, The Prostate.

Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer.

A. Renshaw, A. D'Amico, J. Richie, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trials.

A. Renshaw, A. D'Amico, J. Richie, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Staging of renal carcinoma using magnetic resonance imaging at 1.5 tesla

H Y Kressel, M A Amendola, H M Pollack, 1990, Cancer.

Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: an active and tolerable outpatient regimen.

R. Mick, A. Wein, D. Vaughn, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictors of patient reported outcomes and cost of care in younger men with newly diagnosed prostate cancer

A. Wein, S. Chhatre, R. Jayadevappa, 2009, The Prostate.